FERAS ALKHARBOUSH: Open Payments
NPI 1194212555 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 48 payments from 6 companies in 2025. Trend: 2023 $605 · 2024 $1,226 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $233 |
| Janssen Pharmaceuticals, Inc | 11 | $231 |
| E.R. Squibb & Sons, L.L.C. | 8 | $192 |
| Otsuka America Pharmaceutical, Inc. | 9 | $191 |
| Alkermes, Inc. | 6 | $150 |
| Luye Pharma (USA) Ltd. | 5 | $116 |
Products named: INVEGA SUSTENNA, UZEDY, COBENFY, ARISTADA, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
